Vesicular Monoamine Transporter Substrate/Inhibitor Activity of MPTP/MPP+ Derivatives: A Structure–Activity Study
- 26 January 2008
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 51 (4) , 760-768
Abstract
The active metabolite of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP), N-methyl-4-phenylpyridinium (MPP+), selectively destroys the dopaminergic neurons and induces the symptoms of Parkinson’s disease. Inhibition of mitochondrial complex I and/or the perturbation of dopamine metabolism through cellular and granular accumulation have been proposed as some of the major causes of neurotoxicity. In the present study we have synthesized and characterized a number of MPTP and MPP+ derivatives that are suitable for the comparative neurotoxicity and complex I inhibition versus dopamine metabolism perturbation studies. Structure−activity studies with bovine chromaffin granule ghosts show that 3′-hydroxy-MPP+ is one of the best known substrates for the vesicular monoamine transporter (VMAT). A series of compounds that combine the structural features of MPP+ and a previously characterized VMAT inhibitor, 3-amino-2-phenyl-propene, have been identified as the most effective VMAT inhibitors. These derivatives have been used to define the structural requirements of the VMAT substrate and inhibitor activities.Keywords
This publication has 21 references indexed in Scilit:
- The dopamine transporter proteomeJournal of Neurochemistry, 2006
- Kinetic Evidence for Channeling of Dopamine between Monoamine Transporter and Membranous Dopamine-β-monooxygenase in Chromaffin Granule GhostsJournal of Biological Chemistry, 2004
- Dopamine efflux by MPTP and hydroxyl radical generationJournal of Neural Transmission, 2002
- The Reduction of Membrane-bound Dopamine β-Monooxygenase in Resealed Chromaffin Granule GhostsJournal of Biological Chemistry, 1995
- Mono- and binuclear molybdenum and tungsten complexes containing asymmetric bridging ligands: effects of ligand conjugation and conformation on metal-metal interactionsInorganic Chemistry, 1993
- Mono‐ and Binuclear Molybdenum Complexes Incorporating 4‐(4‐Hydroxyphenyl)pyridine: Metal–Metal Interactions Across an Asymmetric Bridging LigandAngewandte Chemie International Edition, 1992
- MPTP mechanisms of neurotoxicity and their implications for Parkinson's diseaseEuropean Journal of Pharmacology: Molecular Pharmacology, 1991
- Structure-neurotoxicity trends of analogues of 1-methyl-4-phenylpyridinium (MPP+), the cytotoxic metabolite of the dopaminergic neurotoxin MPTPLife Sciences, 1990
- Reserpine binding to chromaffin granules suggests the existence of two conformations of the monoamine transporterBiochemistry, 1989
- Inhibition of Norepinephrine Transport and Reserpine Binding by Reserpine DerivativesJournal of Neurochemistry, 1987